Title: The Prospects for Personalized Medicine
Author: Shara Yurkiewicz
Summary: Ten years after the release of a working draft of the human genome, major changes have made their way into medical practice, the marketplace, research, and …
On March 30 the UCLA Medical Institutional Review Board (MIRB) issued its determination regarding a complaint about Dr. John Fahey and allegations that he participated in malariotherapy research at UCLA. The MIRB determined that Fahey, while not personally involved in the clinical trials, was involved in evaluating data and biological samples brought to UCLA from China by Dr. Xiao Peng Chen under the Fogarty International Program. Since Chen’s work was performed as part of the Fogarty Program at UCLA and was under Fahey’s supervision, the MIRB determined that Fahey was engaged in human subjects research. Chen had tested a theory that infecting HIV-positive patients with malaria could help the patient’s body fight off the AIDS-causing disease.